AOD9604 is a peptide fragment (hGH Fragment 177-191) of the C-terminus of Human Growth Hormone to which a tyrosine is added at the N-terminal end. Studies have suggested that AOD9604 is more effective than its predecessor AOD9401 in its ability to stimulate lipolytic (fat burning) and anti-lipogenic activity. Like Growth Hormone, AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (prevents the transformation of fatty food materials into body fat) both in laboratory testing and in animals and humans. Recent clinical research studies have shown that AOD9604 did show a reduction of body fat in the mid abdominal area in both obese, over-weight, and average built people.
Increased muscle mass
Decreased fat mass
Common Dosage is 2-6IU (500-1000 mcg) divided in to 2-3 doses. One in the morning before breakfast, second dose post-training, third before bed.
Administered via intramuscular or subcutaneous injection.
Hypersomnia (excessive sleeping)
Injection Spot Redness
All side effects are manageable after 2-3 days of discontinuing use.
Unopened Vial: 36 months
After reconstitution: Must be used in 14 days and stored between 2°C-8°C
Distributed by: Biolab Peptides